GBS (Group B streptococcus) DNA Diagnostic Kit
Description
Clinical Significances
As an opportunistic pathogen, GBS usually lodges in the vagina and rectum. It belongs to the conditional pathogenic bacteria and pregnant women can be infected and spread the bacteria to the newborn causing neonatal sepsis, meningitis, pneumonia, etc.
This kit is for the detection of GBS DNA in the samples of reproductive tract and rectal secretions, and can be used for the diagnosis of streptococcus B infection and efficacy monitoring after medication. This test is suitable for 34- 37 weeks pregnancy women who have not been given any antibiotics or medicated with suppositories or lotions one week before testing.
Main factor to cause premature rupture of fetal membranes
Easily cause amniotic cavity infection
Increase premature delivery rate by 20% – 60%
Main pathogenic bacterium of puerperal infection
Neonates suffer from septicemia, meningitis and pneumonia or even die
Launched into market for 11 years and detected nearly 10 million cases
The 1 st NMPA approved GBS PCR detection kit in China
Testing report within 4 hours
High sensitivity and strong specificity
Perfect preserved solution for specimen
Combining polymerase chain reaction (PCR) with fluorescent probes labeling technique, this kit can quickly and accurately detect whether objects are infected by GBS with high sensitivity and specificity.
Target Users:
pregnant women and neonates
Specimens:
genital tract and rectum secreta of women, or nasal & pharyngeal swab of neonates
Storage:
kept at -20±5℃ and avoid repeated freezing-thawing.
Packing Specification:
48 tests/kit
